Resolving Inconsistencies for De-identification & Anonymization - McDermott

Resolving Inconsistencies in Requirements for De-identification and Anonymization of Health Data under CCPA, HIPAA, and GDPR

Overview



For companies seeking to use, license, or otherwise commercialize health data, there are potential inconsistencies among the HIPAA de-identification standard, the CCPA definition of de-identified data, and GDPR requirements for anonymization. Learn practical steps to resolve these inconsistencies and reduce the risk of CCPA and GDPR exposure when commercializing data sets de-identified in acordance with the HIPAA de-identification standard.

REGISTRATION INFORMATION

12:00–1:00pm EST

Webinar

Dig Deeper

Cambridge, United Kingdom / Speaking Engagements / July 1-3, 2024

Privacy Laws & Business | 37th International Conference

Washington, DC / Speaking Engagements / May 8-10, 2024

2024 Privacy + Security Spring Academy

Paris, France / McDermott Event / May 30, 2024

New Cybersecurity Challenges (NIS II, CRA, DORA) in the EU and UK

Washington, DC / Speaking Engagements / April 3-4, 2024

IAPP Global Privacy Summit 2024

Webinar / McDermott Webinar / March 19,2024

Healthcare Privacy Risks and Enforcement

Get In Touch